Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Feb;79(4):1235–1239. doi: 10.1073/pnas.79.4.1235

Gene dosage and gene expression in the HLA region: Evidence from deletion variants

Paul Gladstone *, Lucy Fueresz *, Donald Pious *,
PMCID: PMC345936  PMID: 6951171

Abstract

Among variants selected in a human cell line for nonexpression of a single gene product in the HLA complex, most are single-gene variants, but several have been isolated that are cis-acting and abolish expression of a series of closely linked genes. The two most plausible mechanisms by which such variants could arise are mitotic crossing-over and chromosome deletion. In two HLA variants the presence of a visible chromosome deletion, a 50% reduction in activity of glyoxalase I (a closely linked marker), or both provided evidence for deletional origins. In a third variant these changes were not demonstrable. All three variants showed reductions in amount of cell surface HLA antigens: 40% for the Ia antigens (HLA-DR) and 20-25% for HLA-ABC antigens. The reductions in cell surface antigen in deletion variants have an important implication: in the case of the HLA-A, -B, and -C heterodimer, which consists of a subunit coded for within the major histocompatibility complex and another subunit (β2-microglobulin) coded for on a different chromosome, it is the gene of the major histocompatibility complex that is limiting. The nonmutant haplotype includes A2; binding of an A2 monoclonal antibody in two of the mutants was found to be approximately equal to that in the wild-type cells. Thus, loss of one copy of HLA-ABC genes does not lead to gene dosage compensation—i.e., increased activity by the remaining ABC alleles. The results with the two types of antibodies support a deletional mechanism and are inconsistent with mitotic crossing-over. Of interest with respect to the potential use of deletion variants for purposes of mapping is the fact that each of these variants has distinctive breakpoints. The absence of mitotic crossing-over in 1.2 × 107 cells selected suggests that the event is rare in this autosomal region, if it occurs at all.

Keywords: regulation of HLA, mitotic crossing-over, monoclonal antibodies, dosage compensation

Full text

PDF
1235

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H. Genetics of transplantation: the major histocompatibility complex. Annu Rev Genet. 1976;10:319–339. doi: 10.1146/annurev.ge.10.120176.001535. [DOI] [PubMed] [Google Scholar]
  2. Berger R., Bernheim A., Sasportes M., Hauptmann G., Hors J., Legrand L., Fellous M. Regional mapping of the HLA on the short arm of chromosome 6. Clin Genet. 1979 Mar;15(3):245–251. doi: 10.1111/j.1399-0004.1979.tb00975.x. [DOI] [PubMed] [Google Scholar]
  3. Brodsky F. M., Parham P., Barnstable C. J., Crumpton M. J., Bodmer W. F. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979;47:3–61. doi: 10.1111/j.1600-065x.1979.tb00288.x. [DOI] [PubMed] [Google Scholar]
  4. Brown J. P., Klitzman J. M., Hellström K. E. A microassay for antibody binding to tumor cell surface antigens using 125I-labelled protein a from Staphylococcus aureus. J Immunol Methods. 1977;15(1):57–66. doi: 10.1016/0022-1759(77)90017-5. [DOI] [PubMed] [Google Scholar]
  5. Brégégère F., Abastado J. P., Kvist S., Rask L., Lalanne J. L., Garoff H., Cami B., Wiman K., Larhammar D., Peterson P. A. Structure of C-terminal half of two H-2 antigens from cloned mRNA. Nature. 1981 Jul 2;292(5818):78–81. doi: 10.1038/292078a0. [DOI] [PubMed] [Google Scholar]
  6. Campbell C. E., Worton R. G. Segregation of recessive phenotypes in somatic cell hybrids: role of mitotic recombination, gene inactivation, and chromosome nondisjunction. Mol Cell Biol. 1981 Apr;1(4):336–346. doi: 10.1128/mcb.1.4.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cook R. G., Vitetta E. S., Uhr J. W., Capra J. D. Structural studies on the murine Ia alloantigens--III. Tryptic peptide comparisons of allelic products of the I-E/C sub-region. Mol Immunol. 1979 Jan;16(1):29–35. doi: 10.1016/0161-5890(79)90024-5. [DOI] [PubMed] [Google Scholar]
  8. Davis K. A., Williams G. R. Cation activation of glyoxalase I. Biochim Biophys Acta. 1966 Feb 14;113(2):393–395. doi: 10.1016/s0926-6593(66)80078-4. [DOI] [PubMed] [Google Scholar]
  9. Francke U., Pellegrino M. A. Assignment of the major histocompatibility complex to a region of the short arm of human chromosome 6. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1147–1151. doi: 10.1073/pnas.74.3.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Francke U., Weitkamp L. R. Report of the committee on the genetic constitution of chromosome 6. Cytogenet Cell Genet. 1979;25(1-4):32–38. doi: 10.1159/000131397. [DOI] [PubMed] [Google Scholar]
  11. Gladstone P., Pious D. Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant. Somatic Cell Genet. 1980 Mar;6(2):285–298. doi: 10.1007/BF01538802. [DOI] [PubMed] [Google Scholar]
  12. Gladstone, Pious D. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature. 1978 Feb 2;271(5644):459–461. doi: 10.1038/271459a0. [DOI] [PubMed] [Google Scholar]
  13. Holtkamp B., Cramer M., Lemke H., Rajewsky K. Isolation of a cloned cell line expressing variant H-2Kk using fluorescence-activated cell sorting. Nature. 1981 Jan 1;289(5793):66–68. doi: 10.1038/289066a0. [DOI] [PubMed] [Google Scholar]
  14. Kavathas P., Bach F. H., DeMars R. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4251–4255. doi: 10.1073/pnas.77.7.4251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Klinger H. P. Rapid processing of primary embryonic tissues for chromosome banding pattern analysis. Cytogenetics. 1972;11(5):424–435. doi: 10.1159/000130208. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Old L. J., Stockert E., Boyse E. A., Kim J. H. Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med. 1968 Mar 1;127(3):523–539. doi: 10.1084/jem.127.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pious D., Hawley P., Forrest G. Isolation and characterization of HL-A variants in cultured human lymphoid cells. Proc Natl Acad Sci U S A. 1973 May;70(5):1397–1400. doi: 10.1073/pnas.70.5.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pious D., Martin S., Gladstone P., Soderland C. Linked marker analysis of spontaneous HLA variants of somatic cells. Somatic Cell Genet. 1980 Jul;6(4):529–541. doi: 10.1007/BF01539154. [DOI] [PubMed] [Google Scholar]
  20. Rosenstraus M. J., Chasin L. A. Separation of linked markers in Chinese hamster cell hybrids: mitotic recombination is not involved. Genetics. 1978 Dec;90(4):735–760. doi: 10.1093/genetics/90.4.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sato K., Slesinski R. S., Littlefield J. W. Chemical mutagenesis at the phosphoribosyltransferase locus in cultured human lymphoblasts. Proc Natl Acad Sci U S A. 1972 May;69(5):1244–1248. doi: 10.1073/pnas.69.5.1244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Seabright M. A rapid banding technique for human chromosomes. Lancet. 1971 Oct 30;2(7731):971–972. doi: 10.1016/s0140-6736(71)90287-x. [DOI] [PubMed] [Google Scholar]
  23. Tarrant G. M., Holliday R. A search for allelic recombination in Chinese hamster cell hybrids. Mol Gen Genet. 1977 Nov 18;156(3):273–279. doi: 10.1007/BF00267182. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES